Is American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists SCI Indexed? Indexing Status & Metrics

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor

2.93

Citation rate 1.34 955 total citations

h5-index 34 h5 depth signal

Cited share 46.1% 341 of 739

Total citations 955 Citation footprint

Metric signal 1.41 External metric anchor

Self-citation 21.6% 206 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 2,726

Canada 57

Australia 36

United Kingdom 25

Spain 20

Citing Fields of Research

Patient Care 1,746

Pharmacology & Toxicology 708

Medical Ethics 686

Health Education & Remote Healthcare 556

Healthcare Policy 540

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 31,991 Articles tracked across the journal lifetime

Indexed publication set 739 341 cited publications

Last 12 months 403 33.6 publications/month

Open access share 8.2% 33 OA publications in the last year

Leading citing country United States 2,726 citing publications

Leading citing field Patient Care 1,746 citing publications

Latest tracked publication 19 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE

v52n1,Jan. 1, 1995-

PubMed

v52n1,Jan. 1, 1995-

Hospital and health administration index

v52n1,Jan. 1, 1995-1999

Index medicus

Active Coverage

Research Focus & Classification

Indexed Subjects

Patient Care Medical Ethics Antibiotic & Antibacterial Agents Pharmacology & Toxicology Health Education & Remote Healthcare Healthcare Policy

Issuing & Sponsoring Bodies

Contributor

American Society of Health-System Pharmacists

Broad Categories

Hospitals Pharmacy Patient Care Medical Ethics Cardiology Antibiotic & Antibacterial Agents Hematology

MeSH Descriptors

Drug Therapy Pharmaceutical Preparations Pharmacy Service, Hospital.

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01 19 October 2026

DOI 10.1093/ajhp/zxag348

Assessing Medication Confounders Before Determination of Brain Death/Death by Neurologic Criteria: A Primer, with Opioids as a Worked Example

Open DOI

Brian L Erstad, Aarti Sarwal, Yugant Khand et al.

Purpose: To provide a primer on how clinicians, particularly pharmacists, can systematically assess whether a medication may confound determination of brain death/death by neurologic criteria (BD/DNC), using pharmacokinetic and pharmacod...

02 16 October 2026

DOI 10.1093/ajhp/zxag239

Symptom-monitored loading: An evaluation of prophylactic medications in patients with severe alcohol withdrawal

Open DOI

Andraya Hawks, Alexis Robinson, Pari Iverson et al.

Purpose: The purpose of this study was to evaluate differences in outcomes among patients with severe alcohol withdrawal syndrome (AWS) who received symptom-monitored loading (SML) regimens of lorazepam, chlordiazepoxide, or gabapentin a...

03 16 October 2026

DOI 10.1093/ajhp/zxag238

2026-2027 Board of Directors Photos

Open DOI

04 15 October 2026

DOI 10.1093/ajhp/zxag346

An Evaluation of Insulin Use in Hospitalized Patients with Corticosteroid-Related Hyperglycemia

Open DOI

Alexis Clarke, Sarah Ferrell, Blake Burton et al.

Purpose: This study evaluated insulin use in hospitalized patients who developed corticosteroid-related hyperglycemia to assess current insulin management strategies, glycemic outcomes, and opportunities for optimizing institutional prac...

05 14 October 2026

DOI 10.1093/ajhp/zxag345

Implementing a Multidisciplinary Fentanyl Patch Verification Workflow Across a 12-Hospital Health System

Open DOI

Francis Zamora, Michelle Krichbaum, Devada Franco Singh et al.

Purpose: To describe the development, implementation, and early experience of a multidisciplinary opioid stewardship workflow designed to improve the safety of transdermal fentanyl ordering across a 12-hospital health system. Summary: A ...

06 14 October 2026

DOI 10.1093/ajhp/zxag343

Reply to Ariano et al

Open DOI

Wendy L St. Peter, Andrew S Bzowyckyj, Manjunath P Pai

07 14 October 2026

DOI 10.1093/ajhp/zxag344

Postoperative length of stay comparison associated with a switch from alvimopan to naloxegol in patients undergoing major small and large bowel procedures

Open DOI

Hanna M Schultz, Doug Raiff

Purpose: This retrospective analysis compares postoperative length of stay in patients undergoing colorectal surgery who received naloxegol or alvimopan as part of an Enhanced Recovery After Surgery (ERAS) protocol. Methods: This is a sy...

08 14 October 2026

DOI 10.1093/ajhp/zxag331